Guardant Health
GH
#1809
Rank
A$16.40 B
Marketcap
A$125.05
Share price
-0.89%
Change (1 day)
87.12%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): A-$5.06

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is A-$4.62. In 2024 the company made an earnings per share (EPS) of A-$4.97 an increase over its 2023 EPS that were of A-$5.98.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$5.061.84%
2024A-$4.97-16.82%
2023A-$5.98-33.13%
2022A-$8.9460%
2021A-$5.5855.04%
2020A-$3.60207.14%
2019A-$1.17-19.81%
2018A-$1.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
A-$3.88-16.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
A-$2.99-35.35%๐Ÿ‡บ๐Ÿ‡ธ USA